drugset
drugset / Trial / NCT00047476

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

NCT00047476 ↗

Phase 2 Completed 160 enrolled Celgene Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy of dexmethylphenidate (d-MPH) in the treatment of chemotherapy-related fatigue in adult cancer subjects.

Timeline

Start
2002-06
Primary completion
—
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject dexmethylphenidate Unknown — —

Indications

neoplasm